BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Parkin A, Man J, Timpson P, Pajic M. Targeting the complexity of Src signalling in the tumour microenvironment of pancreatic cancer: from mechanism to therapy. FEBS J 2019;286:3510-39. [PMID: 31330086 DOI: 10.1111/febs.15011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Cai Y, Xu J, Cheng Q. Proto-oncogene tyrosine-protein kinase SRC (Src) inhibition in microglia relieves neuroinflammation in neuropathic pain mouse models. Bioengineered 2021;12:11390-8. [PMID: 34851237 DOI: 10.1080/21655979.2021.2008694] [Reference Citation Analysis]
2 Porazinski S, Parkin A, Pajic M. Rho-ROCK Signaling in Normal Physiology and as a Key Player in Shaping the Tumor Microenvironment. Adv Exp Med Biol 2020;1223:99-127. [PMID: 32030687 DOI: 10.1007/978-3-030-35582-1_6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
3 Creeden JF, Alganem K, Imami AS, Brunicardi FC, Liu SH, Shukla R, Tomar T, Naji F, McCullumsmith RE. Kinome Array Profiling of Patient-Derived Pancreatic Ductal Adenocarcinoma Identifies Differentially Active Protein Tyrosine Kinases. Int J Mol Sci 2020;21:E8679. [PMID: 33213062 DOI: 10.3390/ijms21228679] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
4 Yan W, Liu X, Wang Y, Han S, Wang F, Liu X, Xiao F, Hu G. Identifying Drug Targets in Pancreatic Ductal Adenocarcinoma Through Machine Learning, Analyzing Biomolecular Networks, and Structural Modeling. Front Pharmacol 2020;11:534. [PMID: 32425783 DOI: 10.3389/fphar.2020.00534] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
5 Zhao Y, Bilal M, Raza A, Khan MI, Mehmood S, Hayat U, Hassan STS, Iqbal HMN. Tyrosine kinase inhibitors and their unique therapeutic potentialities to combat cancer. Int J Biol Macromol 2021;168:22-37. [PMID: 33290765 DOI: 10.1016/j.ijbiomac.2020.12.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
6 Valdoz JC, Johnson BC, Jacobs DJ, Franks NA, Dodson EL, Sanders C, Cribbs CG, Van Ry PM. The ECM: To Scaffold, or Not to Scaffold, That Is the Question. Int J Mol Sci 2021;22:12690. [PMID: 34884495 DOI: 10.3390/ijms222312690] [Reference Citation Analysis]
7 Khoruddin NA, Noorizhab MN, Teh LK, Mohd Yusof FZ, Salleh MZ. Pathogenic nsSNPs that increase the risks of cancers among the Orang Asli and Malays. Sci Rep 2021;11:16158. [PMID: 34373545 DOI: 10.1038/s41598-021-95618-y] [Reference Citation Analysis]
8 Papatsirou M, Artemaki PI, Karousi P, Scorilas A, Kontos CK. Circular RNAs: Emerging Regulators of the Major Signaling Pathways Involved in Cancer Progression. Cancers (Basel) 2021;13:2744. [PMID: 34205978 DOI: 10.3390/cancers13112744] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Edwards P, Kang BW, Chau I. Targeting the Stroma in the Management of Pancreatic Cancer. Front Oncol 2021;11:691185. [PMID: 34336679 DOI: 10.3389/fonc.2021.691185] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Stopa KB, Kusiak AA, Szopa MD, Ferdek PE, Jakubowska MA. Pancreatic Cancer and Its Microenvironment-Recent Advances and Current Controversies. Int J Mol Sci 2020;21:E3218. [PMID: 32370075 DOI: 10.3390/ijms21093218] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
11 Rozengurt E, Eibl G. Crosstalk between KRAS, SRC and YAP Signaling in Pancreatic Cancer: Interactions Leading to Aggressive Disease and Drug Resistance. Cancers (Basel) 2021;13:5126. [PMID: 34680275 DOI: 10.3390/cancers13205126] [Reference Citation Analysis]
12 Fu Z, Wang L, Li S, Chen F, Au-Yeung KK, Shi C. MicroRNA as an Important Target for Anticancer Drug Development. Front Pharmacol 2021;12:736323. [PMID: 34512363 DOI: 10.3389/fphar.2021.736323] [Reference Citation Analysis]
13 Li ZY, Sun XY. Recent progress in SRC targeted therapy for pancreatic cancer. Shijie Huaren Xiaohua Zazhi 2021; 29(12): 621-627 [DOI: 10.11569/wcjd.v29.i12.621] [Reference Citation Analysis]
14 Li L, Pan Y, Mo X, Wei T, Song J, Luo M, Huang G, Teng C, Liang K, Mao N, Yang J. A novel metastatic promoter CEMIP and its downstream molecular targets and signaling pathway of cellular migration and invasion in SCLC cells based on proteome analysis. J Cancer Res Clin Oncol 2020;146:2519-34. [PMID: 32648226 DOI: 10.1007/s00432-020-03308-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Naydenov NG, Lechuga S, Zalavadia A, Mukherjee PK, Gordon IO, Skvasik D, Vidovic P, Huang E, Rieder F, Ivanov AI. P-Cadherin Regulates Intestinal Epithelial Cell Migration and Mucosal Repair, but Is Dispensable for Colitis Associated Colon Cancer. Cells 2022;11:1467. [PMID: 35563773 DOI: 10.3390/cells11091467] [Reference Citation Analysis]
16 Caner A, Asik E, Ozpolat B. SRC Signaling in Cancer and Tumor Microenvironment. Adv Exp Med Biol 2021;1270:57-71. [PMID: 33123993 DOI: 10.1007/978-3-030-47189-7_4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
17 Zhang C, Huang L, Xiong J, Xie L, Ying S, Jia Y, Yao Y, Song X, Zeng Z, Yuan J. Isoalantolactone inhibits pancreatic cancer proliferation by regulation of PI3K and Wnt signal pathway. PLoS One 2021;16:e0247752. [PMID: 33661942 DOI: 10.1371/journal.pone.0247752] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
18 Yao J, Shen Q, Huang M, Ding M, Guo Y, Chen W, Lin Y, Zheng Y, Yu S, Yan W, Su T, Liu Z, Lu L. Screening tumor specificity targeted by arnicolide D, the active compound of Centipeda minima and molecular mechanism underlying by integrative pharmacology. J Ethnopharmacol 2022;282:114583. [PMID: 34487850 DOI: 10.1016/j.jep.2021.114583] [Reference Citation Analysis]
19 Cox D. How not to discover a drug - integrins. Expert Opin Drug Discov 2021;16:197-211. [PMID: 32921156 DOI: 10.1080/17460441.2020.1819234] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]